Brief: Larimar Therapeutics Announces Proposed Underwritten Public Offering
Larimar Therapeutics Inc LRMR.O: LARIMAR THERAPEUTICS ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING LARIMAR THERAPEUTICS - LEERINK PARTNERS AND GUGGENHEIM SECURITIES ARE JOINT BOOKRUNNING MANAGERS FOR OFFERING LARIMAR THERAPEUTICS INC - GRANTS UNDERWRITERS OPTION TO BUY 15% MORE SECURITIES Source text: ID:nGNX3q91L0 Further company coverage: LRMR.O
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update